Monograph

C01CA01 - Etilefrine

Propably not porphyrinogenic

Rationale

Non-CYP metabolism. No data pointing to CYP-interaction.

Chemical description

Structurally related to endogenous adrenaline, lacking one catechol-hydroxy moiety, and N-ethyl substituent instead of N-methy.

Therapeutic characteristics

Adrenergic substance used in hypotension.

Metabolism and pharmacokinetics

Metabolized by conjugation to sulfates and glucuronides and by deamination to hydroxymandelic acid.

Personal communication

None

Published experience

None

Similar drugs

Explore alternative drugs in similar therapeutic classes C01C / C01CA or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Belgium